Director/PDMR Shareholding

RNS Number : 7172H

Deltex Medical Group PLC

18 March 2015

 

Deltex Medical Group plc
("Deltex Medical" or "the Company")

Director/PDMR Shareholding

18 March 2015 - Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring ("ODM"), announces that Mr Ewan Phillips, Chief Executive, has informed the Company that he has exercised options over 600,000 shares under the Company's Enterprise Management Incentive ("EMI") scheme.

Following the exercise Mr. Phillips owns 2,645,189 ordinary shares, representing 1.24 per cent. of the issued share capital of the Company.

Application will be made for the shares to be admitted to trading on AIM ("Admission") to occur on or around 24 March 2015. Following Admission, the total number of voting rights in the Company will be 213,617,689. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

For further information, please contact:-

Deltex Medical Group plc	01243 774 837 [e-mail]
Nigel Keen, Chairman
Ewan Phillips, Chief Executive
Paul Mitchell, Finance Director
Barry Curtis, Company Secretary
Nominated Adviser & Broker
Arden Partners plc	020 7614 5900
Chris Hardie
Joint Broker Zeus Capital Limited Dominic Wilson John Goold	020 7533 7727
Financial Public Relations
Newgate	020 7653 9850
Tim Thompson
Robyn McConnachie Ed Treadwell

 

END

 

 

RDSLFFILVSIDLIE